Inventor · disambiguated record
Jason S. Lewis
Also filed as: LEWIS JASON · LEWIS JASON S · LEWIS JASON STUART
21 granted patents·25 pending applications·122 citations·filing 2010–2025
94Inventor score
Files withMEMORIAL SLOAN KETTERING CANCER CENTER27SLOAN KETTERING INST CANCER RES8ADJUVANCE TECH INC5SLOAN KETTERING INST CANCER4BRADBURY MICHELLE1
Top patents by PatentIndex Score
46 records- 0194US10548998B2Multimodal silica-based nanoparticlesSLOAN KETTERING INST CANCER RES·Filed 2018·Granted Feb 4, 2020·19 cites·36 claims
- 0293US11419955B2Multimodal silica-based nanoparticlesSLOAN KETTERING INST CANCER RES·Filed 2019·Granted Aug 23, 2022·5 cites·17 claims
- 0393US10548989B2Nanoparticle immunoconjugatesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Feb 4, 2020·7 cites·20 claims
- 0493US10039847B2Multimodal silica-based nanoparticlesSLOAN KETTERING INST CANCER RES·Filed 2017·Granted Aug 7, 2018·15 cites·16 claims
- 0592US10906926B2Triterpene saponin analoguesADJUVANCE TECH INC·Filed 2020·Granted Feb 2, 2021·6 cites·21 claims
- 0692US10548997B2Fluorescent silica-based nanoparticlesSLOAN KETTERING INST CANCER RES·Filed 2017·Granted Feb 4, 2020·14 cites·13 claims
- 0792US9999694B2Multimodal silica-based nanoparticlesSLOAN KETTERING INST CANCER RES·Filed 2014·Granted Jun 19, 2018·19 cites·48 claims
- 0891US11274116B2Minimal saponin analogues, synthesis and use thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Mar 15, 2022·3 cites·10 claims
- 0986US10626137B2Minimal saponin analogues, synthesis and use thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted Apr 21, 2020·2 cites·5 claims
- 1086US9625456B2Fluorescent silica-based nanoparticlesBRADBURY MICHELLE·Filed 2010·Granted Apr 18, 2017·25 cites·13 claims
- 1183US11597764B2Anti-L1-CAM antibodies and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Mar 7, 2023·3 cites·19 claims
- 1282US11607465B2Uses of labeled HSP90 inhibitorsSLOAN KETTERING INST CANCER RES·Filed 2020·Granted Mar 21, 2023·1 cites·8 claims
- 1378US12441789B2DLL3-targeting antibodies and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Oct 14, 2025·1 cites·17 claims
- 1478US12187755B2Minimal saponin analogues, synthesis and use thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Granted Jan 7, 2025·0 cites·13 claims
- 1578US12037355B2Triterpene saponin analoguesADJUVANCE TECH INC·Filed 2023·Granted Jul 16, 2024·0 cites·20 claims
- 1678US11446400B2Free PSA antibodies as diagnostics, prognostics and therapeutics for prostate cancerMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Sep 20, 2022·1 cites·8 claims
- 1777US11135320B2Radioligands for pretargeted pet imaging and methods of their therapeutic useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Oct 5, 2021·1 cites·9 claims
- 1877US2024327443A1Triterpene saponin analoguesADJUVANCE TECH INC·Filed 2024·Application pending·0 cites
- 1977US2024058482A1Uses of labeled hsp90 inhibitorsSLOAN KETTERING INST CANCER RES·Filed 2023·Application pending·0 cites
- 2074US12486323B2Anti-L1-CAM antibodies and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Granted Dec 2, 2025·0 cites·9 claims
- 2174US2023037294A1Nanoparticle immunoconjugatesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 2273US2023040245A1Free psa antibodies as diagnostics, prognostics and therapeutics for prostate cancerMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 2372US12161734B2Multimodal silica-based nanoparticlesSLOAN KETTERING INST CANCER RES·Filed 2022·Granted Dec 10, 2024·0 cites·17 claims
- 2468US2025223311A1Minimal saponin analogues, synthesis and use thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2025·Application pending·0 cites
- 2566US2020353096A1Nanoparticle immunoconjugatesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Application pending·0 cites
- 2664US2021002316A1Triterpene saponin analoguesADJUVANCE TECH INC·Filed 2020·Application pending·0 cites
- 2762US2024216557A1Radioligand binding to anti-dll3 antibodies for pretargeted pet imaging and therapeutic uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 2862US2024368269A1Anti-dll3 antibodies and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 2962US2020206369A1Imaging of tumor-associated macrophagesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Application pending·0 cites
- 3062US2022040337A1Radioligands for pretargeted pet imaging and methods of their therapeutic useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 3158US2018327436A1Triterpene saponin analoguesADJUVANCE TECH INC·Filed 2016·Application pending·0 cites
- 3256US2023372551A1Radiolabeled ligands for targeted pet/spect imaging and methods of their useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 3355US2023241259A1IMAGING COMPOUNDS SELECTIVE FOR NaV1.7MEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 3454US2024115721A1Anti-dll3 antibody-drug conjugateMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 3554US2024115720A1Antibody-pyrrolobenzodiazepine derivative conjugateMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 3653US2016082137A1Clinical Multimodality-Tools for Pre-And Intraoperative Insulinoma DiagnosticsSLOAN KETTERING INST CANCER·Filed 2014·Application pending·0 cites
- 3753US2021283281A1Radiolabeled ligands for targeted pet/spect imaging and methods of their useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Application pending·0 cites
- 3850US2022089663A1PROTEINS AND FLUOROPHORE-CONTAINING COMPOUNDS SELECTIVE FOR NaV1.7MEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Application pending·0 cites
- 3950US2015359913A1Tetrazines/trans-cyclooctenes in solid phase synthesis of labeled peptidesSLOAN KETTERING INST CANCER·Filed 2014·Application pending·0 cites
- 4049US2014308204A1Free psa antibodies as diagnostics, prognostics and therapeutics for prostate cancerSLOAN KETTERING INST CANCER·Filed 2012·Application pending·0 cites
- 4149US2016331852A1Radioligands for pretargeted pet imaging and methods of their therapeutic useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Application pending·0 cites
- 4247US10821195B2Compositions for therapeutics, targeted PET imaging and methods of their useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Nov 3, 2020·0 cites·22 claims
- 4347US2018140725A1Imaging of tumor-associated macrophagesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Application pending·0 cites
- 4444US2016228589A1Methods and compositions for imaging disorders using polyspecific agentsSLOAN-KETTERING INST FOR CANCER RES·Filed 2014·Application pending·0 cites
- 4541US10512700B2Radiohalide-labeled targeted diagnostics and therapeuticsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted Dec 24, 2019·0 cites·52 claims
- 4636US2015343100A1Bimodal fluorophore-labeled liposomes and associated methods and systemsSLOAN KETTERING INST CANCER·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jason S. Lewis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →